VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
Illustration for: AI Chip Startup Etched Hits $10.3B Valuation
← Value Add PulseFUNDING$300M Series C at $10.3B

AI Chip Startup Etched Hits $10.3B Valuation

Etched closed a $300 million Series C at a $10.3 billion valuation for its transformer-specific AI chips, doubling down as investors look for alternatives to Nvidia's grip on inference hardware.

$300M Series C
Raised
$10.3B
New valuation
~$5B
Prior valuation
~$1B booked
Customer contracts
~$800M
Total disclosed funding
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 23, 2026
2 min read
ShareXLinkedInEmail
THE RUNDOWN
1

Etched closed a $300 million Series C at a $10.3 billion valuation, roughly double the ~$5 billion mark it held just months earlier, with existing investor Jane Street separately reported to be in talks to lead an even larger round at a $20 billion valuation

2

The company has booked roughly $1 billion in customer contracts and has around $800 million in total disclosed funding, targeting hyperscale cloud providers and dedicated AI platform companies looking for inference-optimized silicon rather than general-purpose GPUs

3

It's part of a broader $10.7 billion that has flowed into seed-through-pre-IPO semiconductor rounds in 2026, as investors search for credible alternatives to Nvidia amid supply constraints and China export restrictions squeezing the traditional GPU supply chain

4

The round lands the same week Nvidia's own China revenue has fallen to essentially zero and a rival chipmaker, AMD, won a marquee Microsoft Azure deployment -- reinforcing that 2026 is the year serious money finally bets on Nvidia alternatives at scale

TC
The VC Read · Trace's TakeTrace Cohen

Doubling a valuation in a few months without a closed follow-on round yet is a flashing signal that this market is starting to price inference-chip alternatives on FOMO as much as fundamentals -- which isn't automatically wrong, it's just a different underwriting standard than the seed round these investors wrote 18 months ago. The founders who win this category will be the ones who land one undeniable hyperscaler logo, not the ones with the best benchmark slide; watch customer announcements, not valuation headlines, to know who's actually winning.

AI Chip Wars →

Etched, the AI chip startup building processors specialized for transformer-model inference rather than general-purpose GPU workloads, closed a $300 million Series C at a $10.3 billion valuation -- roughly double the approximately $5 billion mark it held just a few months ago. Jane Street, an existing investor, is separately reported to be in talks to lead an even larger financing at a $20 billion valuation, though that round had not closed as of mid-July.

The jump reflects both Etched's own traction and a broader market repricing of AI chip alternatives. The company says it has booked roughly $1 billion in customer contracts and has around $800 million in total disclosed funding to date, with its pitch centered on hyperscale cloud providers and dedicated AI platform companies that want inference-optimized silicon rather than paying Nvidia's premium for flexible-but-generic GPU capacity.

“Watch whether the reported $20 billion Jane Street round actually closes, and whether Etched names its first major cloud customer publicly.”

Etched competes in an increasingly crowded but still Nvidia-dominated field alongside Cerebras, Groq and a wave of newer entrants, all chasing the same thesis: that as inference volume dwarfs training volume industry-wide, purpose-built chips can undercut general-purpose GPUs on cost per token even if they're less flexible. Roughly $10.7 billion has flowed into seed-through-pre-IPO semiconductor rounds industry-wide in 2026, a sign investors increasingly believe at least some of that thesis will pay off.

The timing compounds the story. Nvidia's own China revenue has fallen to essentially zero amid export restrictions, AMD just won a marquee Microsoft Azure deployment for its Helios rack-scale platform, and Jensen Huang has spent the week publicly defending competitors' access to Chinese AI models rather than talking up Nvidia's own roadmap. For the first time in years, serious late-stage capital is flowing to Nvidia alternatives at a scale that could actually matter to hyperscaler purchasing decisions rather than remaining a venture-stage curiosity.

For VCs, the read is that inference-specific silicon has crossed from thesis to allocatable category -- a $10.3 billion mark for a company that was worth half that a few months ago is the kind of re-rating that pulls more capital into the category fast. The risk is concentration: a huge share of Etched's implied value depends on landing and keeping a handful of hyperscaler-scale customers, and any stumble on manufacturing yield or a competitive chip from Nvidia itself could compress the multiple quickly. Watch whether the reported $20 billion Jane Street round actually closes, and whether Etched names its first major cloud customer publicly.

ShareXLinkedInEmail
More onNvidia →

Originally reported by TechCrunch. Analysis and editorial commentary by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

FUNDING· Jul 22, 2026

Cathedral, Ex-DOGE Founders' Startup, Raises $160M

Illustration for: Cathedral, Ex-DOGE Founders' Startup, Raises $160M
FUNDING$160M at $1.4B Valuation

Cathedral, Ex-DOGE Founders' Startup, Raises $160M

Four former Department of Government Efficiency staffers raised $160 million at a $1.4 billion valuation for Cathedral, an AI-driven military cyber startup backed by Andreessen Horowitz and Sequoia Capital.

FUNDING· Jul 22, 2026

Glow Exits Stealth With $180M at $1.2B Valuation

Illustration for: Glow Exits Stealth With $180M at $1.2B Valuation
FUNDING$180M at $1.2B valuation

Glow Exits Stealth With $180M at $1.2B Valuation

Glow, founded by former Meta, Snowflake and Claroty executives, emerged from stealth with $180 million at a $1.2 billion valuation to rebuild endpoint security for a world where AI agents, not just employees, operate on corporate devices.

FUNDING· Jul 22, 2026

Crystalys Raises $130M to Push Gout Drug Through Phase 3

Illustration for: Crystalys Raises $130M to Push Gout Drug Through Phase 3
FUNDING$130M Series B

Crystalys Raises $130M to Push Gout Drug Through Phase 3

Crystalys Therapeutics raised a $130 million Series B led by Frazier Life Sciences to fund global Phase 3 trials of dotinurad, an oral gout drug already approved in five Asian markets, less than a year after a $205 million Series A.

@Trace_Cohen·t@nyvp.com